Patent ID: 11964047
Assignee: ETERNATEAR, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 14:
15. A method of recreating or building one or more layers of an eye's tear film comprising the step of:
administering an ophthalmic suspension to an eye of a patient in need of treatment, the ophthalmic suspension comprising
i) an aqueous phase comprising water and one or more components selected from the group consisting of at least one wax ester, at least one anionic polar surfactant, at least one nonionic surfactant, at least one salt, and at least one phosphate; and
ii) an oil phase comprising at least one mineral oil and, optionally, at least one wax ester,

wherein, upon administration, the ophthalmic suspension recreates or rebuilds the one or more layers of the eye's tear film, and
wherein the ophthalmic suspension exhibits a Zeta potential of from about −60 mV to about −110 mV.